RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

Clinical trial NCT05765500 · RECRUITING

Trial details

NCT number: NCT05765500
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostatic Neoplasms

Start date: 2024-02-12
Primary completion: 2027-07-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.